Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Br J Anaesth (2000) 85(1):13642
PMID 25520039
Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK
Gastrointestinal symptoms represent the most frequent Retatrutide side effects
One is dermatology journals, cautious, hedged, full of phrases like "inconclusive" and "further research needed." The other is skin clinics selling injection packages, confident, glossy, and light on caveats
US$ 24.50
US$ 25.78
US$ 23.01
US$ 27.69
US$ 24.83
US$ 25.06
US$ 29.54
